Mice lacking serum amyloid P component do not necessarily develop severe autoimmune disease

Biochem Biophys Res Commun. 2001 Aug 10;286(1):200-5. doi: 10.1006/bbrc.2001.5364.

Abstract

Serum amyloid P component (SAP) is a major acute-phase reactant in mice. Recently, it was reported that SAP-deficient mice spontaneously developed anti-nuclear antibodies and severe glomerulonephritis. Because the SAP-deficient mice we generated display no obvious phenotypic abnormalities, we investigated whether our SAP-deficient mice would also spontaneously develop autoimmune responses. In accordance with the report, our mice produced high titers of anti-nuclear antibody but did not develop severe glomerulonephritis. On the other hand, it was recently reported that SAP bound to gram-negative bacteria via lipopolysaccharide (LPS) prevented LPS-mediated activation of a classical complement pathway. Thus, we asked if SAP-deficient mice would show altered responses to an intraperitoneal injection of LPS from Salmonella typhimirium. SAP-deficiency did afford resistance to lethality induced by high-dose LPS. Our experiments clearly showed that contrary to documented data, SAP-deficient mice do not develop serious autoimmune disease and we suggest that SAP has a critical role in LPS toxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoimmune Diseases / genetics
  • Autoimmune Diseases / physiopathology*
  • Base Sequence
  • DNA Primers
  • Female
  • Lipopolysaccharides / administration & dosage
  • Male
  • Mice
  • Mice, Knockout
  • Salmonella typhimurium / metabolism
  • Serum Amyloid P-Component / genetics
  • Serum Amyloid P-Component / physiology*

Substances

  • DNA Primers
  • Lipopolysaccharides
  • Serum Amyloid P-Component